- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05175911
Implementation of the Golden Hour for Preterm Infants : a Quality Improvement Study
March 7, 2022 updated by: Tribolet Sophie, Centre Hospitalier Universitaire de Liege
Implementation of the "Golden Hour", an Initial Standardized Stabilization of Preterm Less Than 31 Weeks and/or 1300 g : a Quality Improvement Study
Effective initial stabilization of preterm neonates in the initial 60 minutes of life ("golden hour") was shown to improve outcomes.
Keys components include anticipative and collaborative approach, respiratory support, thermal regulation and early initiation of parenteral nutrition.
The objective is to complete the admission within 60 minutes of delivery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sophie Tribolet
- Phone Number: 003243215648
- Email: sophie.tribolet@chuliege.Be
Study Locations
-
-
-
Liège, Belgium, 4000
- Recruiting
- Chu Liege
-
Contact:
- Sophie Tribolet
- Email: sophie.tribolet@chuliege.be
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 hour (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Premature younger than 31 weeks of gestational age or less than 1300 g expected
Description
Inclusion Criteria:
- Premature infants (< 31 weeks' gestation)
- Infants with expected weight less than 1300 g
- Inborn babies
Exclusion Criteria:
- Infants outborn
- Infants with major congenital anomalies (laparoschisis, omphalocèle, diaphragmatic hernia, …)
- Parental refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
premature infants
premature infants less than 31 weeks of gestation or weighting less than 1300 g
|
This is a quality improvement project to evaluate the implementation of "Golden hour", a standardized stabilization during the first hour of life in inborn preterm infants younger than 31 weeks of gestational age or weighting less than 1300 g in the NICU of the University of Liege. There is no comparative arm. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion of the procedure : closing time of the incubator
Time Frame: 1 hour
|
Number of minutes of life at incubator closure
|
1 hour
|
|
Glycemia at admission and within 24 hours
Time Frame: 24 hours
|
blood glucose measurement on admission and then every 3 hours for the first 24 hours of life
|
24 hours
|
|
Thermal stability : temperature at admission and at the end of the procedure
Time Frame: 1 hour
|
1 hour
|
|
|
Mortality rate
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Process of the procedure:
Time Frame: 1 hour
|
Number of minutes of life at initiation of parenteral nutrition, caffeine and antibiotics administration.
|
1 hour
|
|
Incidence of hypotension and bradycardia
Time Frame: 1 hour
|
1 hour
|
|
|
Intubation rate and duration of mechanical ventilation
Time Frame: 3 months
|
Number of hours of mechanical ventilation
|
3 months
|
|
Need for surfactant administration and time of administration
Time Frame: 3 days
|
Number of hours of life at surfactant administration
|
3 days
|
|
Comorbidities of prematurity: NEC, BPD, ROP, sepsis, PDA, cPVL, IVH
Time Frame: 3 months
|
3 months
|
|
|
Duration of hospital stay (only if no transfer)
Time Frame: 3 months
|
3 months
|
|
|
Caregiver's perception of the procedure: stress…
Time Frame: 24 hours
|
use of a questionnaire adapted from the "Teamwork Perceptions Questionnaire (T-TPQ)"
|
24 hours
|
|
Parental experience of the procedure
Time Frame: 24 hours
|
24 hours
|
|
|
Conditions of the procedure : realization during the night shift and team composition
Time Frame: 24 hours
|
collection of the time and date of performance and the number of nurses, doctors, fellows,...
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 10, 2022
Primary Completion (Anticipated)
March 1, 2023
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
December 1, 2021
First Submitted That Met QC Criteria
December 14, 2021
First Posted (Actual)
January 4, 2022
Study Record Updates
Last Update Posted (Actual)
March 9, 2022
Last Update Submitted That Met QC Criteria
March 7, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GOLDEN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
-
Elgan Pharma Ltd.Terminated
-
Hôpital de la Croix-RousseUnknownPremature Birth of NewbornFrance